Delivery Order SPE2DB24D2106-SPE2DB25FAVDJ
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,785.80, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a firm fixed-price delivery order under the DLA's SPE2DB Indefinite Delivery Contract, which has a ceiling value of $499,999,999 and enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,508.60 firm fixed-price delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and...
This federal contract award is a $624,516.90 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The delivery order, which is not associated with any set-aside designation, was awarded under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA for the provision of a comprehensive range of pharmaceutical products, including branded and...
This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $76,011.60, is a firm fixed-price delivery order under the DLA's SPE2DB Indefinite Delivery Contract, which has a ceiling value of $499,999,999. The contract covers the provision of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $78,006.06 for pharmaceutical products and medical supplies. The award was made by the Defense Logistics Agency (DLA), a defense agency, under the SPE2DB indefinite delivery contract (IDC) program, which has a total potential value of $499,999,999 and is valid through November 2026. The contract covers a comprehensive range of pharmaceutical items, including branded and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $82,417.09. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $16,678.36, is a delivery order under the SPE2DB Indefinite Delivery Contract (IDC) program, which has a total potential value of $499,999,999 and is valid through November 2026. The contract is for the delivery of a range of pharmaceutical products, including branded and generic...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,443.50 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valid through April 2025, is for the provision of pharmaceutical products and medical supplies to the DLA's Medical Supply Chain. This contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) awarded to DMS Pharmaceutical Group, enabling the DLA to issue delivery orders for a comprehensive...
This federal contract award is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program, which is a multi-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the delivery of pharmaceutical products, including branded and generic prescription drugs, over-the-counter...
The federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $5,678.70 award is part of the Defense Logistics Agency's SPE2DB program, a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a...